Guo, J.; Xiong, S.; Zhang, X.; Gong, W.; Si, Y.; Ma, D.; Li, F.; Han, Y.
Preclinical Efficacy and Safety of an Oncolytic Adenovirus KD01 for the Treatment of Bladder Cancer. Pharmaceuticals 2025, 18, 511.
https://doi.org/10.3390/ph18040511
AMA Style
Guo J, Xiong S, Zhang X, Gong W, Si Y, Ma D, Li F, Han Y.
Preclinical Efficacy and Safety of an Oncolytic Adenovirus KD01 for the Treatment of Bladder Cancer. Pharmaceuticals. 2025; 18(4):511.
https://doi.org/10.3390/ph18040511
Chicago/Turabian Style
Guo, Jin, Shengfeng Xiong, Xinyuan Zhang, Wei Gong, Yao Si, Ding Ma, Fei Li, and Yingyan Han.
2025. "Preclinical Efficacy and Safety of an Oncolytic Adenovirus KD01 for the Treatment of Bladder Cancer" Pharmaceuticals 18, no. 4: 511.
https://doi.org/10.3390/ph18040511
APA Style
Guo, J., Xiong, S., Zhang, X., Gong, W., Si, Y., Ma, D., Li, F., & Han, Y.
(2025). Preclinical Efficacy and Safety of an Oncolytic Adenovirus KD01 for the Treatment of Bladder Cancer. Pharmaceuticals, 18(4), 511.
https://doi.org/10.3390/ph18040511